Your browser doesn't support javascript.
loading
Towards Improving Embryo Prioritization: Parallel Next Generation Sequencing of DNA and RNA from a Single Trophectoderm Biopsy.
Fuchs Weizman, Noga; Wyse, Brandon A; Antes, Ran; Ibarrientos, Zenon; Sangaralingam, Mugundhine; Motamedi, Gelareh; Kuznyetsov, Valeriy; Madjunkova, Svetlana; Librach, Clifford L.
Afiliación
  • Fuchs Weizman N; CReATe Fertility Centre, Toronto, Canada.
  • Wyse BA; CReATe Fertility Centre, Toronto, Canada. brandon@createivf.com.
  • Antes R; CReATe Fertility Centre, Toronto, Canada.
  • Ibarrientos Z; CReATe Fertility Centre, Toronto, Canada.
  • Sangaralingam M; CReATe Fertility Centre, Toronto, Canada.
  • Motamedi G; CReATe Fertility Centre, Toronto, Canada.
  • Kuznyetsov V; CReATe Fertility Centre, Toronto, Canada.
  • Madjunkova S; CReATe Fertility Centre, Toronto, Canada. svetlana@createivf.com.
  • Librach CL; CReATe Fertility Centre, Toronto, Canada.
Sci Rep ; 9(1): 2853, 2019 02 27.
Article en En | MEDLINE | ID: mdl-30814554
ABSTRACT
Improved embryo prioritization is crucial in optimizing the results in assisted reproduction, especially in light of increasing utilization of elective single embryo transfers. Embryo prioritization is currently based on morphological criteria and in some cases incorporates preimplantation genetic testing for aneuploidy (PGT-A). Recent technological advances have enabled parallel genomic and transcriptomic assessment of a single cell. Adding transcriptomic analysis to PGT-A holds promise for better understanding early embryonic development and implantation, and for enhancing available embryo prioritization tools. Our aim was to develop a platform for parallel genomic and transcriptomic sequencing of a single trophectoderm (TE) biopsy, that could later be correlated with clinical outcomes. Twenty-five embryos donated for research were utilized; eight for initial development and optimization of our method, and seventeen to demonstrate clinical safety and reproducibility of this method. Our method achieved 100% concordance for ploidy status with that achieved by the classic PGT-A. All sequencing data exceeded quality control metrics. Transcriptomic sequencing data was sufficient for performing differential expression (DE) analysis. All biopsies expressed specific TE markers, further validating the accuracy of our method. Using PCA, samples clustered in euploid and aneuploid aggregates, highlighting the importance of controlling for ploidy in every transcriptomic assessment.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Blastocisto / Fertilización In Vitro / Desarrollo Embrionario / Secuenciación de Nucleótidos de Alto Rendimiento Límite: Adult / Female / Humans Idioma: En Revista: Sci Rep Año: 2019 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Blastocisto / Fertilización In Vitro / Desarrollo Embrionario / Secuenciación de Nucleótidos de Alto Rendimiento Límite: Adult / Female / Humans Idioma: En Revista: Sci Rep Año: 2019 Tipo del documento: Article País de afiliación: Canadá